JP2013511481A5 - - Google Patents

Download PDF

Info

Publication number
JP2013511481A5
JP2013511481A5 JP2012539237A JP2012539237A JP2013511481A5 JP 2013511481 A5 JP2013511481 A5 JP 2013511481A5 JP 2012539237 A JP2012539237 A JP 2012539237A JP 2012539237 A JP2012539237 A JP 2012539237A JP 2013511481 A5 JP2013511481 A5 JP 2013511481A5
Authority
JP
Japan
Prior art keywords
chromatography
process according
glycoprotein
steps
size exclusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012539237A
Other languages
English (en)
Japanese (ja)
Other versions
JP5840135B2 (ja
JP2013511481A (ja
Filing date
Publication date
Priority claimed from EP09014585A external-priority patent/EP2325194A1/en
Application filed filed Critical
Publication of JP2013511481A publication Critical patent/JP2013511481A/ja
Publication of JP2013511481A5 publication Critical patent/JP2013511481A5/ja
Application granted granted Critical
Publication of JP5840135B2 publication Critical patent/JP5840135B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012539237A 2009-11-24 2010-11-24 糖タンパク質の精製のためのプロセス Expired - Fee Related JP5840135B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26393109P 2009-11-24 2009-11-24
EP09014585A EP2325194A1 (en) 2009-11-24 2009-11-24 Process for the purification of glycoproteins
EP09014585.5 2009-11-24
US61/263,931 2009-11-24
PCT/EP2010/007115 WO2011063943A1 (en) 2009-11-24 2010-11-24 Process for the purification of glycoproteins

Publications (3)

Publication Number Publication Date
JP2013511481A JP2013511481A (ja) 2013-04-04
JP2013511481A5 true JP2013511481A5 (cg-RX-API-DMAC7.html) 2013-11-28
JP5840135B2 JP5840135B2 (ja) 2016-01-06

Family

ID=42173838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012539237A Expired - Fee Related JP5840135B2 (ja) 2009-11-24 2010-11-24 糖タンパク質の精製のためのプロセス

Country Status (12)

Country Link
US (1) US8846344B2 (cg-RX-API-DMAC7.html)
EP (2) EP2325194A1 (cg-RX-API-DMAC7.html)
JP (1) JP5840135B2 (cg-RX-API-DMAC7.html)
KR (1) KR101860830B1 (cg-RX-API-DMAC7.html)
CN (1) CN102656182B (cg-RX-API-DMAC7.html)
AU (1) AU2010324104C1 (cg-RX-API-DMAC7.html)
CA (1) CA2781132A1 (cg-RX-API-DMAC7.html)
DK (1) DK2504350T3 (cg-RX-API-DMAC7.html)
ES (1) ES2626248T3 (cg-RX-API-DMAC7.html)
LT (1) LT2504350T (cg-RX-API-DMAC7.html)
PL (1) PL2504350T3 (cg-RX-API-DMAC7.html)
WO (1) WO2011063943A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7470672B2 (en) 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种促性腺激素的纯度测定方法
BR112016023680A2 (pt) * 2014-04-18 2017-08-15 Cadila Healthcare Ltd ?processo de purificação de gonadotropina?
AU2015248793A1 (en) 2014-04-18 2016-11-03 Glycotope Gmbh Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone
ES2719748T3 (es) * 2014-05-23 2019-07-12 Inst Massone S A Proceso para obtener HMG-UP (gonadotropina menopáusica humana con grado de ultrapureza) y una composición libre de contaminantes
BR112018003455A2 (pt) 2015-09-17 2018-09-25 Glycotope Gmbh composição ou composição farmacêutica e uso da composição
SG11201808354PA (en) * 2016-03-31 2018-10-30 Spark Therapeutics Inc Column-based fully scalable raav manufacturing process
CN106008662A (zh) * 2016-05-16 2016-10-12 南京农业大学 一种以枸杞蜂花粉为原料制备富锌中性糖蛋白的方法
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN106732464B (zh) * 2017-02-02 2020-11-20 复旦大学 一种亲水树枝和c18修饰的磁性石墨烯材料及其制备方法和应用
US11385238B2 (en) * 2017-06-30 2022-07-12 Amgen Inc. Methods of protein clips recovery
CN110563832B (zh) * 2019-07-31 2025-11-14 江苏璟泽生物医药有限公司 一种高纯度重组促卵泡刺激素纯化方法
WO2021119404A1 (en) * 2019-12-12 2021-06-17 Emd Millipore Corporation Intensified virus filtration using diafiltration buffer
EP3964523A1 (en) * 2020-09-04 2022-03-09 PreviPharma Consulting GmbH Preparation of fetuin a by hydrophobic interaction chromatography
CN114835796A (zh) * 2022-05-05 2022-08-02 江苏尤里卡生物科技有限公司 一种促性腺激素纯化方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923805A (en) 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US4840896A (en) 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
DE3777623D1 (de) * 1986-12-07 1992-04-23 Morinaga Milk Industry Co Ltd Kolonie-stimulierender faktor und verfahren zu seiner herstellung.
IT1206302B (it) 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
EP1482053A3 (en) 1989-12-22 2007-10-17 Laboratoires Serono SA Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
DE69131978T2 (de) 1990-05-08 2000-10-05 University Of Medicine And Dentistry Of New Jersey, Newark Glykoproteinhormon-analoga mit veränderten immunologischen merkmalen, veränderter wirksamkeit und/oder rezeptorspezifität
DE69231129D1 (de) 1991-06-18 2000-07-06 Univ New Jersey Med Analoga von glykoproteinhormonen mit geänderter rezeptorbindungsspezifität und aktivität und verfahren zur darstellung und verwendung derselben
IL117849A (en) 1995-04-14 2002-07-25 Lepetit Spa Chromatographic process for clearing glycoproteins
UA60311C2 (uk) * 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
IT1287138B1 (it) 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
IL122732A0 (en) 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
PT1775346E (pt) 1997-06-25 2009-08-25 Merck Serono Sa Análogos de hormonas glicoproteicas reticulados com ligações dissulfureto, sua preparação e utilização
US6414123B1 (en) 1997-10-21 2002-07-02 Vitro Diagnostics, Inc. Method for purifying FSH
US6200778B1 (en) 1998-05-07 2001-03-13 Transkaryotic Therapies, Inc. Genomic sequences for protein production and delivery
KR20010083126A (ko) 1998-07-23 2001-08-31 피터 지. 스트링거 여포자극 호르몬 및 여포자극 호르몬 변이체 제형, 제품및 방법
AU779005B2 (en) 1999-04-16 2004-12-23 Instituto Massone S.A. Highly purified gonadotropin compositions and process for preparing them
AU2001231531A1 (en) 2000-02-11 2001-08-20 Maxygen Aps Follicle stimulating hormones
SE0001660D0 (sv) 2000-05-05 2000-05-05 Gramineer Ab Separation of glyco-containing entities
JP4699991B2 (ja) 2003-04-02 2011-06-15 アレス トレーディング ソシエテ アノニム 非イオン性界面活性剤を一緒に伴うfsh及びlhの液体医薬組成物
ES2333128T3 (es) 2003-12-22 2010-02-17 Ares Trading S.A. Metodo para purificar fsh.
US20060026719A1 (en) * 2004-01-14 2006-02-02 Kieliszewski Marcia J Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
CA2573918A1 (en) * 2004-04-19 2005-11-24 Ohio University Cross-linkable glycoproteins and methods of making the same
ES2312037T3 (es) * 2004-11-09 2009-02-16 Ares Trading S.A. Metodo para puruficar fsh.
EP1960419B1 (en) 2005-12-09 2016-03-16 Ares Trading S.A. Method for purifying fsh or a fsh mutant
JP5364382B2 (ja) 2006-02-07 2013-12-11 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 遊離チオール部分を有するタンパク質の安定化された組成物
CN101720332B (zh) 2007-06-28 2014-08-13 拉蒂奥法姆有限责任公司 生产促卵泡激素的细胞克隆
DE102008002209A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin

Similar Documents

Publication Publication Date Title
JP2013511481A5 (cg-RX-API-DMAC7.html)
JP2014500013A5 (cg-RX-API-DMAC7.html)
FI3393510T3 (fi) Zika-virusrokote
CY1116963T1 (el) Μεθοδος για καθαρισμο ανασυνδυασμενης fsh
AR091647A1 (es) Purificacion de iduronato-2-sulfatasa
JP2016519137A5 (cg-RX-API-DMAC7.html)
JP2014519817A5 (cg-RX-API-DMAC7.html)
RU2019144161A (ru) Последовательности нуклеиновых кислот и аминокислотные последовательности аденовирусов человекообразных обезьян, исключая человека, содержащие их векторы и их применения
JOP20130186B1 (ar) تنقية الجزيئات الشبيهة بالفيروسات
JP2011525523A5 (cg-RX-API-DMAC7.html)
NZ590257A (en) Method of preparing alpha-1 proteinase inhibitor
RU2015149979A (ru) Способ очистки белка фактора роста
HRP20211838T1 (hr) Krnji protein vp4 rotavirusa i njegova primjena
JP2013511566A5 (cg-RX-API-DMAC7.html)
WO2018097603A3 (ko) 중동호흡기증후군 코로나바이러스 s 단백질 면역원 조성물 및 이의 제작 방법
JP2018515089A5 (cg-RX-API-DMAC7.html)
JP2017527282A (ja) クチナシ青色素を生成するプロセス
CN106170493A (zh) 促性腺激素的新型纯化方法
Leong et al. Downstream processing of virus‐like particles with aqueous two‐phase systems: Applications and challenges
IL265524B2 (en) Assembled glycoproteins
JP2007523883A5 (cg-RX-API-DMAC7.html)
JP2015536347A5 (cg-RX-API-DMAC7.html)
JPH03173725A (ja) 希土類元素の分別方法
WO2014194362A8 (en) Process for preparing apolipoprotein a-i (apo a-i)
JP2017525752A5 (cg-RX-API-DMAC7.html)